Ligand Pharmaceuticals LGND
NASDAQ LGND
$302.96 +0.22 (+0.07%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) recorded Depreciation & Amortization (CF) of $8.22 million in Q2 2026, down 3.6% from $8.52 million a year earlier and unchanged from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

On a TTM basis, Ligand Pharmaceuticals' Depreciation & Amortization (CF) came in at $32.91 million as of Jun 30, 2026, down 5.7% year-over-year; for FY2025, it was $33.78 million, down 4.2% from FY2024.

  • Annual Depreciation & Amortization (CF) has declined for three straight years, though with a five-year compound annual growth rate of 5.6% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $35.24 million in FY2024 (-3.5%), $36.52 million in FY2023 (-29.1%), $51.53 million in FY2022 (+0.9%) and $51.07 million in FY2021 (+98.8%).
  • Quarterly Depreciation & Amortization (CF) has ranged from $8.21 million in Q4 2025 to $13.66 million in Q1 2022 over the past five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined for five consecutive quarters, with an average decline of 3.2% over the last eight quarters.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 166.4% in Q3 2021, against a decline of 36.1% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $8.22 million (Q1 2026), $8.21 million (Q4 2025) and $8.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 1.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 194.00 Mn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 1.93 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 98.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 1.62 Bn
10 Ligand Pharmaceuticals 6.03 Bn 2.50 Bn - 8.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.22 Mn
Mar 31, 2026 8.22 Mn
Dec 31, 2025 8.21 Mn
Sep 30, 2025 8.27 Mn
Jun 30, 2025 8.52 Mn
Mar 31, 2025 8.77 Mn
Dec 31, 2024 8.63 Mn
Sep 30, 2024 8.99 Mn
Jun 30, 2024 8.85 Mn
Mar 31, 2024 8.77 Mn
Dec 31, 2023 8.92 Mn
Sep 30, 2023 8.61 Mn
Jun 30, 2023 9.50 Mn
Mar 31, 2023 9.50 Mn
Dec 31, 2022 11.14 Mn
Sep 30, 2022 13.48 Mn
Jun 30, 2022 13.27 Mn
Mar 31, 2022 13.66 Mn
Dec 31, 2021 13.17 Mn
Sep 30, 2021 12.72 Mn
API Access

Ligand Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=LGND&period=max&api_key=YOUR_API_KEY